70.31
전일 마감가:
$69.38
열려 있는:
$69.52
하루 거래량:
369.78K
Relative Volume:
0.49
시가총액:
$3.53B
수익:
$1.36B
순이익/손실:
$123.81M
주가수익비율:
29.17
EPS:
2.41
순현금흐름:
$20.35M
1주 성능:
+3.11%
1개월 성능:
+23.59%
6개월 성능:
-21.19%
1년 성능:
-25.83%
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HAE
Haemonetics Corp
|
70.31 | 3.26B | 1.36B | 123.81M | 20.35M | 2.41 |
![]()
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2024-12-06 | 개시 | JP Morgan | Overweight |
2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2024-09-13 | 개시 | CL King | Buy |
2024-09-11 | 개시 | BofA Securities | Neutral |
2024-09-10 | 개시 | BTIG Research | Buy |
2024-06-12 | 업그레이드 | Needham | Hold → Buy |
2022-10-13 | 개시 | Mizuho | Buy |
2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
2021-08-17 | 재개 | Raymond James | Outperform |
2021-06-17 | 개시 | Citigroup | Buy |
2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
2020-01-10 | 개시 | Needham | Buy |
2019-08-07 | 재확인 | Barrington Research | Outperform |
2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2019-05-08 | 재확인 | Barrington Research | Outperform |
2018-08-09 | 재확인 | Barrington Research | Outperform |
2018-02-07 | 재확인 | Barrington Research | Outperform |
2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2017-11-08 | 재확인 | Barrington Research | Outperform |
2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
2016-11-07 | 재확인 | The Benchmark Company | Hold |
2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
2016-08-02 | 재확인 | Jefferies | Buy |
2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Haemonetics Corporation (NYSE:HAE) Q4 2025 Earnings Call Transcript - Insider Monkey
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings - Yahoo Finance
Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lo - GuruFocus
Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lowered Price Target | HAE Stock News - GuruFocus
Raymond James Adjusts Haemonetics (HAE) Price Target to $105, Ma - GuruFocus
Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - GuruFocus
Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Haemonetics (HAE) Rating Maintained, Price Target Lowered to $84 | HAE Stock News - GuruFocus
Haemonetics: Fiscal Q4 Earnings Snapshot - MySA
Transcript : Haemonetics Corporation, Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com
Earnings call transcript: Haemonetics Q4 2025 beats EPS forecast, stock rises - Investing.com
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Haemonetics' Fiscal Q4 Adjusted Earnings Rise, Revenue Falls; Fiscal 2026 Outlook Issued - marketscreener.com
Haemonetics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Haemonetics earnings beat by $0.02, revenue topped estimates - Investing.com
Haemonetics (NYSE:HAE) Surprises With Q1 Sales - Yahoo Finance
Haemonetics Corp Surpasses Q4 Expectations with EPS of $1.17 and Revenue of $331 Million - GuruFocus
Haemonetics (HAE) Surpasses Q4 Revenue Expectations | HAE Stock News - GuruFocus
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow
Haemonetics Corporation announces an Equity Buyback for $500 million worth of its shares. - marketscreener.com
Earnings To Watch: Haemonetics Corp (HAE) Reports Q4 2025 Result - Yahoo Finance
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Gear Up for Haemonetics (HAE) Q4 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Haemonetics Sues Terumo Over Plasma Tech Patents - Law360
Haemonetics (NYSE:HAE) Upgraded to “Buy” at StockNews.com - Defense World
Haemonetics (HAE) Expected to Announce Quarterly Earnings on Thursday - Defense World
BofA Securities’s latest rating for HAE stock - knoxdaily.com
Envestnet Asset Management Inc. Buys 4,217 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Taking on analysts’ expectations and winning: Haemonetics Corp (HAE) - Sete News
How Do Investors Really Feel About Haemonetics?Haemonetics (NYSE:HAE) - Benzinga
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Cerity Partners LLC Decreases Stock Position in Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics Co. (NYSE:HAE) Shares Sold by Legal & General Group Plc - The AM Reporter
Reviewing Haemonetics (NYSE:HAE) and Apyx Medical (NASDAQ:APYX) - Defense World
Is Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts? - Insider Monkey
Patient Blood Management Market is Set to Experience - openPR.com
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know - Yahoo Finance
Haemonetics stock touches 52-week low at $58.24 amid challenges By Investing.com - Investing.com South Africa
Haemonetics stock touches 52-week low at $58.24 amid challenges - Investing.com Australia
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
Vanguard Group Inc. Purchases 10,119 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Prudential Financial Inc. Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
HighTower Advisors LLC Buys 244 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
3 Reasons to Avoid HAE and 1 Stock to Buy Instead - Yahoo Finance
Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? - Insider Monkey
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
10 Pro-Life Companies to Invest In Now - Insider Monkey
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):